All the news articles and press releases in one place.

Date / Time Source Company Sector Market Cap Announcement
03Mar23 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - PDMR Dealing
07Feb23 18:29 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Result of AGM
20Jan23 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Half-Year Trading Update 2023
13Jan23 17:27 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - NOTICE OF 2022 ANNUAL GENERAL MEETING
03Jan23 07:30 RNS Allergy Therapeutics plc Health £42.4m AIM - Suspension - Allergy Therapeutics plc
29Dec22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Annual Report and Accounts Delayed
28Dec22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Director Resignation
08Dec22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Key updates on Grass MATA MPL and VLP Peanut
06Dec22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Appointment of Non-Executive Directors
21Nov22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Appointment of Interim CFO
28Oct22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Allergy to resume UK manufacturing production
19Oct22 15:39 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Holding(s) in Company
17Oct22 13:27 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Allergy Therapeutics – Result of GM
04Oct22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - UK manufacturing update
29Sep22 12:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Allergy Therapeutics at Investor Meet Company
29Sep22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Unaudited Preliminary Results 2022
29Sep22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Subscription and Debt Financing
05Sep22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Allergy Therapeutics at H.C. Wainwright Conference
02Sep22 16:50 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Total Voting Rights
15Jul22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Trading Update and Notice of Results
01Jul22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Allergy Therapeutics at EAACI Congress 2022
26May22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Nick Wykeman to step down as CFO
23May22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Allergy Therapeutics at H.C. Wainwright Conference
25Apr22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Allergy Therapeutics shares data at WAO-BSACI
08Mar22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Allergy Therapeutics at Cowen Health Conference
07Mar22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Allergy Therapeutics at Investor Meet Company
03Mar22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Allergy Therapeutics plc – Interim Results
01Mar22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Allergy Therapeutics shares positive new data
02Feb22 11:05 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Secures new revolving credit facility
01Feb22 14:16 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Total Voting Rights
26Jan22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - FDA clearance of IND application for VLP Peanut
24Jan22 13:13 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Holding(s) in Company
13Jan22 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Half Year Trading Update & Notice of Results
05Jan22 08:47 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Total Voting Rights
25Nov21 09:17 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Allergy Therapeutics: Granting of Awards
23Nov21 12:54 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Result of AGM
11Nov21 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Director Dealings
27Oct21 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Cheryl MacDiarmid appointed to Board of Directors
25Oct21 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Allergy announces positive G309 results
14Oct21 09:24 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Holding(s) in Company
07Oct21 16:37 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Annual Report and AGM Notification
23Sep21 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Preliminary Results for Year ended 30 June 2021
16Sep21 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - ImmunoBON voted Most Innovative Product of 2021
13Sep21 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Secondary endpoints from VLP Peanut 001
09Sep21 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Allergy to Present at H.C. Wainwright Conference
07Sep21 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Allergy to host KOL webinar on VLP Peanut
03Aug21 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Successful primary outcome of VLP Peanut 001
02Aug21 10:57 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Total Voting Rights
14Jul21 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Trading update for the year ended 30 June 2021
08Jul21 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - AGY to present key scientific findings at EAACI
24Jun21 07:00 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Trading Update
01Jun21 15:36 RNS Allergy Therapeutics plc Health £42.4m Allergy Therapeutics - Total Voting Rights
06May21 07:00 RNS Allergy Therapeutics plc Health £42.4m Completion of treatment phase in G309 study
30Apr21 17:47 RNS Allergy Therapeutics plc Health £42.4m Total Voting Rights
16Apr21 07:00 RNS Allergy Therapeutics plc Health £42.4m Appointment of new Group auditors
31Mar21 08:29 RNS Allergy Therapeutics plc Health £42.4m Vesting of Awards under Long Term Incentive Plan
26Mar21 16:39 RNS Allergy Therapeutics plc Health £42.4m Pledge of Shares
11Mar21 12:13 RNS Allergy Therapeutics plc Health £42.4m Pledge of Shares
08Mar21 07:00 RNS Allergy Therapeutics plc Health £42.4m AGY to Present at H.C. Wainwright Conference
03Mar21 07:00 RNS Allergy Therapeutics plc Health £42.4m Interim Results for six months ended 31 Dec 2020
13Jan21 07:00 RNS Allergy Therapeutics plc Health £42.4m Half Year Trading Update 2021 & Notice of Results
05Jan21 07:00 RNS Allergy Therapeutics plc Health £42.4m Initiation of peanut allergy biomarker study
14Dec20 15:58 RNS Allergy Therapeutics plc Health £42.4m Director/PDMR Shareholding
08Dec20 14:42 RNS Allergy Therapeutics plc Health £42.4m Result of Annual General Meeting
20Nov20 13:51 RNS Allergy Therapeutics plc Health £42.4m Grant of Awards under Long Term Incentive Plan
20Nov20 07:00 RNS Allergy Therapeutics plc Health £42.4m Director/PDMR Shareholding
10Nov20 07:05 RNS Allergy Therapeutics plc Health £42.4m Annual Report & Accounts and AGM Notification
26Oct20 07:00 RNS Allergy Therapeutics plc Health £42.4m Initiation of Grass MATA MPL exploratory study
12Oct20 07:00 RNS Allergy Therapeutics plc Health £42.4m Holding(s) in Company
09Oct20 07:00 RNS Allergy Therapeutics plc Health £42.4m Director Dealings and Issue of Equity
23Sep20 07:00 RNS Allergy Therapeutics plc Health £42.4m Preliminary Results
03Sep20 07:00 RNS Allergy Therapeutics plc Health £42.4m AGY secures VLP technology platform
20Jul20 07:30 EQS Allergy Therapeutics plc Health £42.4m Hardman & Co Research: Allergy Therapeutics (AGY): Record sales and a COVID-19 wildcard
15Jul20 07:00 RNS Allergy Therapeutics plc Health £42.4m Trading Update
09Jul20 07:00 RNS Allergy Therapeutics plc Health £42.4m Invalidation of Birch MATA MPL phase III results
01Jul20 17:15 RNS Allergy Therapeutics plc Health £42.4m Total Voting Rights
24Jun20 07:00 RNS Allergy Therapeutics plc Health £42.4m Trading Update
22Apr20 10:11 RNS-R Allergy Therapeutics plc Health £42.4m EAACI review of adjuvants and formulations
01Apr20 13:09 RNS Allergy Therapeutics plc Health £42.4m Grant and Vesting of Awards
09Mar20 07:15 EQS Allergy Therapeutics plc Health £42.4m Hardman & Co Research: Allergy Therapeutics (AGY): Consistent first-half revenue growth
04Mar20 07:00 RNS Allergy Therapeutics plc Health £42.4m Half-year Report
29Jan20 12:00 RNS Allergy Therapeutics plc Health £42.4m Data for peanut allergy vaccine published in JACI
16Jan20 12:25 RNS Allergy Therapeutics plc Health £42.4m Trading Update & Notice of Results - Replacement
16Jan20 08:00 EQS Allergy Therapeutics plc Health £42.4m Hardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average
16Jan20 07:00 RNS Allergy Therapeutics plc Health £42.4m Half Year Trading Update & Notice of Results
02Dec19 09:57 RNS Allergy Therapeutics plc Health £42.4m Holdings in Company
29Nov19 10:34 RNS Allergy Therapeutics plc Health £42.4m Holdings in Company
26Nov19 07:00 RNS Allergy Therapeutics plc Health £42.4m Update to Grass MATA MPL Ph III clinical programme
25Nov19 12:13 RNS Allergy Therapeutics plc Health £42.4m Result of Annual General Meeting
22Oct19 09:23 RNS Allergy Therapeutics plc Health £42.4m Annual Report and Accounts
26Sep19 07:30 EQS Allergy Therapeutics plc Health £42.4m Hardman & Co Research: Allergy Therapeutics (AGY): Continuing to gain market share
25Sep19 07:00 RNS Allergy Therapeutics plc Health £42.4m Preliminary Results
11Jul19 07:00 RNS Allergy Therapeutics plc Health £42.4m Trading update
01Jul19 07:21 EQS Allergy Therapeutics plc Health £42.4m Hardman & Co Research: Allergy Therapeutics (AGY): Successful legal outcome removes uncertainty
01Jul19 07:16 EQS Allergy Therapeutics plc Health £42.4m Hardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value
27Jun19 07:00 RNS Allergy Therapeutics plc Health £42.4m Successful Litigation Settlement
27Jun19 07:00 RNS Allergy Therapeutics plc Health £42.4m Trading Statement
19Jun19 07:00 RNS Allergy Therapeutics plc Health £42.4m Board Change
11Jun19 07:00 RNS Allergy Therapeutics plc Health £42.4m Holdings in Company
21May19 08:30 EQS Allergy Therapeutics plc Health £42.4m Hardman & Co Research: Titon Holdings Plc (TON): You need hands
Date / Time Source Company % Chg
03Mar23 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - PDMR Dealing
07Feb23 18:29 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Result of AGM
20Jan23 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Half-Year Trading Update 2023
13Jan23 17:27 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - NOTICE OF 2022 ANNUAL GENERAL MEETING
03Jan23 07:30 RNS Allergy Therapeutics plc 0.00%
AIM - Suspension - Allergy Therapeutics plc
29Dec22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Annual Report and Accounts Delayed
28Dec22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Director Resignation
08Dec22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Key updates on Grass MATA MPL and VLP Peanut
06Dec22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Appointment of Non-Executive Directors
21Nov22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Appointment of Interim CFO
28Oct22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy to resume UK manufacturing production
19Oct22 15:39 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Holding(s) in Company
17Oct22 13:27 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics – Result of GM
04Oct22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - UK manufacturing update
29Sep22 12:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics at Investor Meet Company
29Sep22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Unaudited Preliminary Results 2022
29Sep22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Subscription and Debt Financing
05Sep22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics at H.C. Wainwright Conference
02Sep22 16:50 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Total Voting Rights
15Jul22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Trading Update and Notice of Results
01Jul22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics at EAACI Congress 2022
26May22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Nick Wykeman to step down as CFO
23May22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics at H.C. Wainwright Conference
25Apr22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics shares data at WAO-BSACI
08Mar22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics at Cowen Health Conference
07Mar22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics at Investor Meet Company
03Mar22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics plc – Interim Results
01Mar22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics shares positive new data
02Feb22 11:05 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Secures new revolving credit facility
01Feb22 14:16 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Total Voting Rights
26Jan22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - FDA clearance of IND application for VLP Peanut
24Jan22 13:13 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Holding(s) in Company
13Jan22 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Half Year Trading Update & Notice of Results
05Jan22 08:47 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Total Voting Rights
25Nov21 09:17 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics: Granting of Awards
23Nov21 12:54 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Result of AGM
11Nov21 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Director Dealings
27Oct21 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Cheryl MacDiarmid appointed to Board of Directors
25Oct21 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy announces positive G309 results
14Oct21 09:24 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Holding(s) in Company
07Oct21 16:37 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Annual Report and AGM Notification
23Sep21 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Preliminary Results for Year ended 30 June 2021
16Sep21 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - ImmunoBON voted Most Innovative Product of 2021
13Sep21 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Secondary endpoints from VLP Peanut 001
09Sep21 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy to Present at H.C. Wainwright Conference
07Sep21 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy to host KOL webinar on VLP Peanut
03Aug21 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Successful primary outcome of VLP Peanut 001
02Aug21 10:57 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Total Voting Rights
14Jul21 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Trading update for the year ended 30 June 2021
08Jul21 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - AGY to present key scientific findings at EAACI
24Jun21 07:00 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Trading Update
01Jun21 15:36 RNS Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Total Voting Rights
06May21 07:00 RNS Allergy Therapeutics plc 0.00%
Completion of treatment phase in G309 study
30Apr21 17:47 RNS Allergy Therapeutics plc 0.00%
Total Voting Rights
16Apr21 07:00 RNS Allergy Therapeutics plc 0.00%
Appointment of new Group auditors
31Mar21 08:29 RNS Allergy Therapeutics plc 0.00%
Vesting of Awards under Long Term Incentive Plan
26Mar21 16:39 RNS Allergy Therapeutics plc 0.00%
Pledge of Shares
11Mar21 12:13 RNS Allergy Therapeutics plc 0.00%
Pledge of Shares
08Mar21 07:00 RNS Allergy Therapeutics plc 0.00%
AGY to Present at H.C. Wainwright Conference
03Mar21 07:00 RNS Allergy Therapeutics plc 0.00%
Interim Results for six months ended 31 Dec 2020
13Jan21 07:00 RNS Allergy Therapeutics plc 0.00%
Half Year Trading Update 2021 & Notice of Results
05Jan21 07:00 RNS Allergy Therapeutics plc 0.00%
Initiation of peanut allergy biomarker study
14Dec20 15:58 RNS Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
08Dec20 14:42 RNS Allergy Therapeutics plc 0.00%
Result of Annual General Meeting
20Nov20 13:51 RNS Allergy Therapeutics plc 0.00%
Grant of Awards under Long Term Incentive Plan
20Nov20 07:00 RNS Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
10Nov20 07:05 RNS Allergy Therapeutics plc 0.00%
Annual Report & Accounts and AGM Notification
26Oct20 07:00 RNS Allergy Therapeutics plc 0.00%
Initiation of Grass MATA MPL exploratory study
12Oct20 07:00 RNS Allergy Therapeutics plc 0.00%
Holding(s) in Company
09Oct20 07:00 RNS Allergy Therapeutics plc 0.00%
Director Dealings and Issue of Equity
23Sep20 07:00 RNS Allergy Therapeutics plc 0.00%
Preliminary Results
03Sep20 07:00 RNS Allergy Therapeutics plc 0.00%
AGY secures VLP technology platform
20Jul20 07:30 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Record sales and a COVID-19 wildcard
15Jul20 07:00 RNS Allergy Therapeutics plc 0.00%
Trading Update
09Jul20 07:00 RNS Allergy Therapeutics plc 0.00%
Invalidation of Birch MATA MPL phase III results
01Jul20 17:15 RNS Allergy Therapeutics plc 0.00%
Total Voting Rights
24Jun20 07:00 RNS Allergy Therapeutics plc 0.00%
Trading Update
22Apr20 10:11 RNS-R Allergy Therapeutics plc 0.00%
EAACI review of adjuvants and formulations
01Apr20 13:09 RNS Allergy Therapeutics plc 0.00%
Grant and Vesting of Awards
09Mar20 07:15 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Consistent first-half revenue growth
04Mar20 07:00 RNS Allergy Therapeutics plc 0.00%
Half-year Report
29Jan20 12:00 RNS Allergy Therapeutics plc 0.00%
Data for peanut allergy vaccine published in JACI
16Jan20 12:25 RNS Allergy Therapeutics plc 0.00%
Trading Update & Notice of Results - Replacement
16Jan20 08:00 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average
16Jan20 07:00 RNS Allergy Therapeutics plc 0.00%
Half Year Trading Update & Notice of Results
02Dec19 09:57 RNS Allergy Therapeutics plc 0.00%
Holdings in Company
29Nov19 10:34 RNS Allergy Therapeutics plc 0.00%
Holdings in Company
26Nov19 07:00 RNS Allergy Therapeutics plc 0.00%
Update to Grass MATA MPL Ph III clinical programme
25Nov19 12:13 RNS Allergy Therapeutics plc 0.00%
Result of Annual General Meeting
22Oct19 09:23 RNS Allergy Therapeutics plc 0.00%
Annual Report and Accounts
26Sep19 07:30 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Continuing to gain market share
25Sep19 07:00 RNS Allergy Therapeutics plc 0.00%
Preliminary Results
11Jul19 07:00 RNS Allergy Therapeutics plc 0.00%
Trading update
01Jul19 07:21 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Successful legal outcome removes uncertainty
01Jul19 07:16 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value
27Jun19 07:00 RNS Allergy Therapeutics plc 0.00%
Successful Litigation Settlement
27Jun19 07:00 RNS Allergy Therapeutics plc 0.00%
Trading Statement
19Jun19 07:00 RNS Allergy Therapeutics plc 0.00%
Board Change
11Jun19 07:00 RNS Allergy Therapeutics plc 0.00%
Holdings in Company
21May19 08:30 EQS Allergy Therapeutics plc 0.00%
Hardman & Co Research: Titon Holdings Plc (TON): You need hands
Date / Time Company % Chg
03Mar23 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - PDMR Dealing
07Feb23 18:29 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Result of AGM
20Jan23 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Half-Year Trading Update 2023
13Jan23 17:27 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - NOTICE OF 2022 ANNUAL GENERAL MEETING
03Jan23 07:30 Allergy Therapeutics plc 0.00%
AIM - Suspension - Allergy Therapeutics plc
29Dec22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Annual Report and Accounts Delayed
28Dec22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Director Resignation
08Dec22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Key updates on Grass MATA MPL and VLP Peanut
06Dec22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Appointment of Non-Executive Directors
21Nov22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Appointment of Interim CFO
28Oct22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy to resume UK manufacturing production
19Oct22 15:39 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Holding(s) in Company
17Oct22 13:27 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics – Result of GM
04Oct22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - UK manufacturing update
29Sep22 12:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics at Investor Meet Company
29Sep22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Unaudited Preliminary Results 2022
29Sep22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Subscription and Debt Financing
05Sep22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics at H.C. Wainwright Conference
02Sep22 16:50 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Total Voting Rights
15Jul22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Trading Update and Notice of Results
01Jul22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics at EAACI Congress 2022
26May22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Nick Wykeman to step down as CFO
23May22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics at H.C. Wainwright Conference
25Apr22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics shares data at WAO-BSACI
08Mar22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics at Cowen Health Conference
07Mar22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics at Investor Meet Company
03Mar22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics plc – Interim Results
01Mar22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics shares positive new data
02Feb22 11:05 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Secures new revolving credit facility
01Feb22 14:16 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Total Voting Rights
26Jan22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - FDA clearance of IND application for VLP Peanut
24Jan22 13:13 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Holding(s) in Company
13Jan22 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Half Year Trading Update & Notice of Results
05Jan22 08:47 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Total Voting Rights
25Nov21 09:17 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy Therapeutics: Granting of Awards
23Nov21 12:54 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Result of AGM
11Nov21 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Director Dealings
27Oct21 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Cheryl MacDiarmid appointed to Board of Directors
25Oct21 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy announces positive G309 results
14Oct21 09:24 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Holding(s) in Company
07Oct21 16:37 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Annual Report and AGM Notification
23Sep21 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Preliminary Results for Year ended 30 June 2021
16Sep21 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - ImmunoBON voted Most Innovative Product of 2021
13Sep21 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Secondary endpoints from VLP Peanut 001
09Sep21 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy to Present at H.C. Wainwright Conference
07Sep21 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Allergy to host KOL webinar on VLP Peanut
03Aug21 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Successful primary outcome of VLP Peanut 001
02Aug21 10:57 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Total Voting Rights
14Jul21 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Trading update for the year ended 30 June 2021
08Jul21 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - AGY to present key scientific findings at EAACI
24Jun21 07:00 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Trading Update
01Jun21 15:36 Allergy Therapeutics plc 0.00%
Allergy Therapeutics - Total Voting Rights
06May21 07:00 Allergy Therapeutics plc 0.00%
Completion of treatment phase in G309 study
30Apr21 17:47 Allergy Therapeutics plc 0.00%
Total Voting Rights
16Apr21 07:00 Allergy Therapeutics plc 0.00%
Appointment of new Group auditors
31Mar21 08:29 Allergy Therapeutics plc 0.00%
Vesting of Awards under Long Term Incentive Plan
26Mar21 16:39 Allergy Therapeutics plc 0.00%
Pledge of Shares
11Mar21 12:13 Allergy Therapeutics plc 0.00%
Pledge of Shares
08Mar21 07:00 Allergy Therapeutics plc 0.00%
AGY to Present at H.C. Wainwright Conference
03Mar21 07:00 Allergy Therapeutics plc 0.00%
Interim Results for six months ended 31 Dec 2020
13Jan21 07:00 Allergy Therapeutics plc 0.00%
Half Year Trading Update 2021 & Notice of Results
05Jan21 07:00 Allergy Therapeutics plc 0.00%
Initiation of peanut allergy biomarker study
14Dec20 15:58 Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
08Dec20 14:42 Allergy Therapeutics plc 0.00%
Result of Annual General Meeting
20Nov20 13:51 Allergy Therapeutics plc 0.00%
Grant of Awards under Long Term Incentive Plan
20Nov20 07:00 Allergy Therapeutics plc 0.00%
Director/PDMR Shareholding
10Nov20 07:05 Allergy Therapeutics plc 0.00%
Annual Report & Accounts and AGM Notification
26Oct20 07:00 Allergy Therapeutics plc 0.00%
Initiation of Grass MATA MPL exploratory study
12Oct20 07:00 Allergy Therapeutics plc 0.00%
Holding(s) in Company
09Oct20 07:00 Allergy Therapeutics plc 0.00%
Director Dealings and Issue of Equity
23Sep20 07:00 Allergy Therapeutics plc 0.00%
Preliminary Results
03Sep20 07:00 Allergy Therapeutics plc 0.00%
AGY secures VLP technology platform
20Jul20 07:30 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Record sales and a COVID-19 wildcard
15Jul20 07:00 Allergy Therapeutics plc 0.00%
Trading Update
09Jul20 07:00 Allergy Therapeutics plc 0.00%
Invalidation of Birch MATA MPL phase III results
01Jul20 17:15 Allergy Therapeutics plc 0.00%
Total Voting Rights
24Jun20 07:00 Allergy Therapeutics plc 0.00%
Trading Update
22Apr20 10:11 Allergy Therapeutics plc 0.00%
EAACI review of adjuvants and formulations
01Apr20 13:09 Allergy Therapeutics plc 0.00%
Grant and Vesting of Awards
09Mar20 07:15 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Consistent first-half revenue growth
04Mar20 07:00 Allergy Therapeutics plc 0.00%
Half-year Report
29Jan20 12:00 Allergy Therapeutics plc 0.00%
Data for peanut allergy vaccine published in JACI
16Jan20 12:25 Allergy Therapeutics plc 0.00%
Trading Update & Notice of Results - Replacement
16Jan20 08:00 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average
16Jan20 07:00 Allergy Therapeutics plc 0.00%
Half Year Trading Update & Notice of Results
02Dec19 09:57 Allergy Therapeutics plc 0.00%
Holdings in Company
29Nov19 10:34 Allergy Therapeutics plc 0.00%
Holdings in Company
26Nov19 07:00 Allergy Therapeutics plc 0.00%
Update to Grass MATA MPL Ph III clinical programme
25Nov19 12:13 Allergy Therapeutics plc 0.00%
Result of Annual General Meeting
22Oct19 09:23 Allergy Therapeutics plc 0.00%
Annual Report and Accounts
26Sep19 07:30 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Continuing to gain market share
25Sep19 07:00 Allergy Therapeutics plc 0.00%
Preliminary Results
11Jul19 07:00 Allergy Therapeutics plc 0.00%
Trading update
01Jul19 07:21 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Allergy Therapeutics (AGY): Successful legal outcome removes uncertainty
01Jul19 07:16 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value
27Jun19 07:00 Allergy Therapeutics plc 0.00%
Successful Litigation Settlement
27Jun19 07:00 Allergy Therapeutics plc 0.00%
Trading Statement
19Jun19 07:00 Allergy Therapeutics plc 0.00%
Board Change
11Jun19 07:00 Allergy Therapeutics plc 0.00%
Holdings in Company
21May19 08:30 Allergy Therapeutics plc 0.00%
Hardman & Co Research: Titon Holdings Plc (TON): You need hands